Webinar will discuss pill formulations of GLP-1s

Endocrine Society experts will discuss the next evolution of anti-obesity medications, including the first pill formulations of GLP-1s, during a Virtual Science Writers Conference on December 10.

What: The Virtual Science Writers Conference will examine:

• Oral formulations of GLP-1s
• Dual and triple agonists—medications that work by activating multiple hormone receptors    

Who:

• Priya Jaisinghani, M.D., D.A.B.O.M., Clinical Assistant Professor, NYU Langone in New York, N.Y.
• Mehmet Furkan Burak, M.D., of Brigham and Women’s Hospital and Harvard Medical School in Boston, Mass. 

When: Wednesday, December 10 at 11 AM Eastern

Please register here to attend the virtual Science Writers Conference.

The recording of this event will be made available on the Society’s YouTube channel for other audiences.

Eli Lilly provided support for this event.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.